Few drugs in the last century have changed the landscape of healthcare and weight management like GLP-1 agonist drugs — drugs like Ozempic and WeGovy.

On this week’s episode of Well, Now we talk with Harvard professor and clinician Dr. Fatima Cody Stanford.

Her research revolutionized obesity medicine and helped pave the way to get a diabetes drug approved for treating a condition millions have in the U.S.

If you liked this episode, check out – Doctors Agree: Obesity is a Disease. The Public Needs to Catch Up.

Well, Now is hosted by Dr. Kavita Patel and registered dietitian nutritionist Maya Feller.

Editing and podcast production by Vic Whitley-Berry.

Production assistance from Kristie Taiwo-Makanjuola.

Editorial oversight by Alicia Montgomery.

Send your comments and recommendations on what to cover to wellnow@slate.com

Learn more about your ad choices. Visit megaphone.fm/adchoices

Well, Now: The Full Truth About Ozempic 49:39 Share

Slate Conversations

Shownotes Transcript

Well, Now: The Full Truth About Ozempic